Evidence map›Paper›PMID 26040656›Full record

ArticleBMC genomics2015

Direct ChIP-Seq significance analysis improves target prediction.

Mukesh Bansal, Geetu Mendiratta, Santosh Anand, Ritu Kushwaha, Ryan Kim, Manju Kustagi, Archana Iyer, Raju S K Chaganti, Andrea Califano, Pavel Sumazin

Abstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Tubular FoxP2 and Kidney Fibrosis.Journal of the American Society of Nephrology : JASN · 2025
    Article
  2. White-opaque switching inMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  3. Article
  4. ChIP-seq identifiesFrontiers in physiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mukesh Bansal
Geetu Mendiratta
Santosh Anand
Ritu Kushwaha
Ryan Kim
Manju Kustagi
Archana Iyer
Raju S K Chaganti
Andrea Califano
Pavel Sumazin

Funding

Nation Center: Multi-Scale Study- Cellular Networks(RMI)U54CA121852 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CALIFANO, ANDREA · 2005 to 2015
$37.4M
NCI NIH HHS 5U54 CA121852-08
6 · The paper itself

Abstract

backgroundChromatin immunoprecipitation followed by sequencing of protein-bound DNA fragments (ChIP-Seq) is an effective high-throughput methodology for the identification of context specific DNA fragments that are bound by specific proteins in vivo. Despite significant progress in the bioinformatics analysis of this genome-scale data, a number of challenges remain as technology-dependent biases, including variable target accessibility and mappability, sequence-dependent variability, and non-specific binding affinity must be accounted for. RESULTS AND DISCUSSION: We introduce a nonparametric method for scoring consensus regions of aligned immunoprecipitated DNA fragments when appropriate control experiments are available. Our method uses local models for null binding; these are necessary because binding prediction scores based on global models alone fail to properly account for specialized features of genomic regions and chance pull downs of specific DNA fragments, thus disproportionally rewarding some genomic regions and decreasing prediction accuracy. We make no assumptions about the structure or amplitude of bound peaks, yet we show that our method outperforms leading methods developed using either global or local null hypothesis models for random binding. We test prediction performance by comparing analyses of ChIP-seq, ChIP-chip, motif-based binding-site prediction, and shRNA assays, showing high reproducibility, binding-site enrichment in predicted target regions, and functional regulation of predicted targets.

conclusionsGiven appropriate controls, a direct nonparametric method for identifying transcription-factor targets from ChIP-Seq assays may lead to both higher sensitivity and higher specificity, and should be preferred or used in conjunction with methods that use parametric models for null binding.

Indexed as

AlgorithmsBase SequenceCell LineChromatin ImmunoprecipitationComputational BiologyConsensus SequenceDNAHigh-Throughput Nucleotide SequencingHomeodomain ProteinsHumansNanog Homeobox ProteinOligonucleotide Array Sequence AnalysisReceptor, Notch1Sequence AlignmentSequence Analysis, DNASOXB1 Transcription FactorsDNAHomeodomain ProteinsNanog Homeobox ProteinNANOG protein, humanNOTCH1 protein, humanReceptor, Notch1SOX2 protein, humanSOXB1 Transcription Factors

Identifiers

PMID26040656
PMCPMC4460594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.